Evaluation of three automated chromogenic FVIII kits for the diagnosis of mild discrepant haemophilia A

International Journal of Laboratory Hematology

Volumn 31, Issue 2, 2009, Pages 180-188

  Rodgers, S E ^a   Duncan, E M ^a   Sobieraj Teague, M ^a   Lloyd, J V ^a  

^a INSTITUTE OF MEDICAL AND VETERINARY SCIENCE   (Australia)

Author keywords

Chromogenic FVIII; Discrepant mild haemophilia; FVIII assay; Haemophilia; Two stage FVIII

Indexed keywords

BLOOD CLOTTING FACTOR 8;

ARTICLE; AUTOMATION; BLOOD SAMPLING; CONTROLLED STUDY; DIAGNOSTIC KIT; HEMOPHILIA A; HUMAN; PRIORITY JOURNAL;

BLOOD COAGULATION; FACTOR VIII; HEMOPHILIA A; HUMANS; MUTATION; REAGENT KITS, DIAGNOSTIC;

EID: 61349120111     PISSN: 17515521     EISSN: 1751553X     Source Type: Journal    
DOI: 10.1111/j.1751-553X.2007.01021.x     Document Type: Article

References (18)

1. Bowyer A.E., Kitchen S. Makris M. (2007) The chromogenic FVIII:C assay is a suitable alternative to the two-stage assay in detection of mild haemophilia A patients with a one-stage, two-stage discrepancy. Journal of Thrombosis and Haemostasis 5 (Suppl. 2 P-S-122 (abstract).
2. Chandler W.L., Ferrell C., Lee J., Tun T. Kha H. (2003) Comparison of three methods for measuring factor VIII levels in plasma. American Journal of Clinical Pathology 120, 34 39.
3. Duncan E.M., Duncan B.M., Tunbridge L.J. Lloyd J.V. (1994) Familial discrepancy between the one-stage and two-stage factor VIII methods in a subgroup of patients with haemophilia A. British Journal of Haematology 87, 846 848.
4. Goodeve A.C. Peake I.R. (2003) The molecular basis of hemophilia A: genotype-phenotype relationships and inhibitor development. Seminars in Thrombosis and Haemostasis 29, 23 30.
5. Goodeve A.C., Hinks J.L., Nesbitt I.M., Sampson B., Burgess C., Khair K., Leisner R., Kitchen S., Peake I.R. Makris M. (2001) Unusual discrepant factor VIII:C assays in haemophilia A patients with Tyr346Cys and Glu321Lys FVIII gene mutations. Thrombosis and Haemostasis Supplement July 2001, Abstract P1370.
6. Hakeos W.H., Miao H., Sirachainan N., Kemball-Cook G., Saenko E.L., Kaufman R.J. Pipe S.W. (2002) Hemophilia A mutations within the factor VIII A2-A3 subunit interface destabilize factor VIIIa and cause one-stage/two-stage activity discrepancy. Thrombosis and Haemostasis 88, 781 787.
7. Hathaway W.E., Christian M.J. Jacobson L.J. (1983) Variant mild hemophilia. Discrepancy in one stage and two stage factor VIII assays. Thrombosis and Haemostasis 50, 357 (abstract).
8. Hubbard A.R., Barrowcliffe T.W., Dodt J., Grancha S., Helgeson E., Jorquera J.I., Metzner H., Mikaelsson M., Oswaldsson U., Smith G., Turecek P.L. Seitz R. (2005) A multi-centre assessment of the chromogenic method for factor VIII: C estimation in plasma-derived and recombinant concentrates. Journal of Thrombosis and Haemostasis (Proc ISTH) 3 (Suppl. 1 Abstract P1246.
9. 1954→Leu substitution in the factor VIII A3 domain. British Journal of Haematology 105, 1123 1126.
10. Kleinveld H.A., Andersson N.-E., van Voorthuizen H., den Hartog J. de Groot P.G. (1999) Determination of coagulation factor VIII activity by a chromogenic substrate method on STA, an automated coagulation analyser. Scandinavian Journal of Clinical and Laboratory Investigation 59, 335 342.
11. Mazurier C., Gaucher C., Jorieux S. Parquet-Gernez A. (1997) Mutations in the FVIII gene in seven families with mild haemophilia A. British Journal of Haematology 96, 426 427 (Letter).
12. Mumford A.D., Laffan M., O'Donnell J., McVey J.H., Johnson D.J.D., Manning R.A. Kemball-Cook G. (2002) A Tyr346→Cys substitution in the interdomain acidic region a1 of factor VIII in an individual with factor VIII:C assay discrepancy. British Journal of Haematology 118, 589 594.
13. Parquet-Gernez A., Mazurier C. Goudemand M. (1988) Functional and immunological assays of FVIII in 133 haemophiliacs - characterization of a subgroup of patients with mild haemophilia A and discrepancy in 1- and 2-stage assays. Thrombosis and Haemostasis 59, 202 206.
14. Pipe S.W., Eickhorst A.N., McKinley S.H., Saenko E.L. Kaufman R.J. (1999) Mild hemophilia A caused by increased rate of factor VIII A2 subunit dissociation: evidence for nonproteolytic inactivation of factor VIIIa in vivo. Blood 93, 176 183.
15. Pipe S.W., Saenko E.L., Eickhorst A.N., Kemball-Cook G. Kaufman R.J. (2001) Hemophilia A mutations associated with 1-stage/2-stage activity discrepancy disrupt protein-protein interactions within the triplicated A domains of thrombin-activated factor VIIIa. Blood 97, 685 691.
16. Rodgers S.E., Duncan E.M., Barbulescu D.M., Quinn D.M. Lloyd J.V. (2007) In vitro kinetics of factor VIII activity in patients with mild haemophilia A and a discrepancy between one-stage and two-stage factor VIII assay results. British Journal of Haematology 136, 138 145.
17. Rudzki Z., Duncan E.M., Casey G.J., Neumann M., Favaloro E.J. Lloyd J.V. (1996) Mutations in a subgroup of patients with mild haemophilia A and a familial discrepancy between the one-stage and two-stage factor VIII:C methods. British Journal of Haematology 94, 400 406.
18. Schwaab R., Oldenburg J., Kemball-Cook G., Albert T., Juhler C., Hanfland P. Ingerslev J. (2000) Assay discrepancy in mild haemophilia A due to a factor VIII missense mutation (Asn694Ile) in a large Danish family. British Journal of Haematology 109, 523 528.